IPONOVA — India's IPO Intelligence Platform

Symbiotec Pharmalab Ltd IPO

Upcoming · Mainboard · BSE, NSE

Last updated:  ·  Compiled by IPONOVA Editorial Desk  ·  How we source data

IPO Details

Price Band₹938.00–₹988.00
Lot Size15 shares
Issue Size₹1,757 Cr
Open Date24 Aug 26
Close Date27 Aug 26
Listing Date01 Sep 26
ExchangeBSE, NSE
Subscription-x

About Symbiotec Pharmalab Ltd

Symbiotec Pharmalab Ltd. is a pharmaceutical and biotechnology company engaged in the development and manufacturing of active pharmaceutical ingredients (APIs), nutritional ingredients, and specialty products.

Frequently Asked Questions

When does the Symbiotec Pharmalab Ltd IPO open and close?
The Symbiotec Pharmalab Ltd IPO opens for subscription on 24 Aug 26. It closes on 27 Aug 26.
What is the price band of Symbiotec Pharmalab Ltd IPO?
The price band of Symbiotec Pharmalab Ltd IPO is ₹938.00 to ₹988.00 per share.
What is the minimum lot size for Symbiotec Pharmalab Ltd IPO?
The minimum lot size for Symbiotec Pharmalab Ltd IPO is 15 shares, requiring a minimum investment of ₹14,820.
When will Symbiotec Pharmalab Ltd list on stock exchanges?
Symbiotec Pharmalab Ltd is expected to list on BSE, NSE on 01 Sep 26.
How can I check Symbiotec Pharmalab Ltd IPO allotment status?
You can check Symbiotec Pharmalab Ltd IPO allotment status on IPONOVA after the basis of allotment is finalized, or via the registrar's website using your PAN number, application number, or DP/Client ID.
How to apply for Symbiotec Pharmalab Ltd IPO?
You can apply for Symbiotec Pharmalab Ltd IPO through your broker's app (Zerodha, Groww, Upstox, etc.) or via UPI-enabled net banking using ASBA. Submit the application during the IPO subscription window with the price within the band ₹938.00 to ₹988.00 per share.

Data Sources & Verification

This page aggregates publicly available data for the Symbiotec Pharmalab Ltd IPO from the following authoritative sources:

Subscription, allotment and listing data is refreshed throughout each IPO's issue window directly from the exchanges and registrars listed above. Always read the official offer document (RHP) before applying. For corrections, contact IPONOVA Editorial Desk.

Read our full editorial methodology & sourcing standards →

Disclaimer: IPONOVA is an information platform only. We are not SEBI-registered investment advisors. All data is presented for educational and informational purposes and is sourced from publicly available filings on BSE, NSE and SEBI. Investment in securities market is subject to market risks. Read all related documents carefully before investing. Past performance is not indicative of future returns. Please consult a SEBI-registered investment advisor before making any investment decisions.